1. Home
  2. ENTA vs ESCA Comparison

ENTA vs ESCA Comparison

Compare ENTA & ESCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • ESCA
  • Stock Information
  • Founded
  • ENTA 1995
  • ESCA 1922
  • Country
  • ENTA United States
  • ESCA United States
  • Employees
  • ENTA N/A
  • ESCA N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • ESCA Recreational Games/Products/Toys
  • Sector
  • ENTA Health Care
  • ESCA Consumer Discretionary
  • Exchange
  • ENTA Nasdaq
  • ESCA Nasdaq
  • Market Cap
  • ENTA 164.6M
  • ESCA 167.7M
  • IPO Year
  • ENTA 2013
  • ESCA N/A
  • Fundamental
  • Price
  • ENTA $8.83
  • ESCA $13.40
  • Analyst Decision
  • ENTA Strong Buy
  • ESCA
  • Analyst Count
  • ENTA 4
  • ESCA 0
  • Target Price
  • ENTA $20.75
  • ESCA N/A
  • AVG Volume (30 Days)
  • ENTA 173.1K
  • ESCA 18.1K
  • Earning Date
  • ENTA 08-11-2025
  • ESCA 08-01-2025
  • Dividend Yield
  • ENTA N/A
  • ESCA 4.48%
  • EPS Growth
  • ENTA N/A
  • ESCA 10.02
  • EPS
  • ENTA N/A
  • ESCA 0.92
  • Revenue
  • ENTA $64,806,000.00
  • ESCA $241,492,000.00
  • Revenue This Year
  • ENTA N/A
  • ESCA N/A
  • Revenue Next Year
  • ENTA $4.05
  • ESCA N/A
  • P/E Ratio
  • ENTA N/A
  • ESCA $14.53
  • Revenue Growth
  • ENTA N/A
  • ESCA N/A
  • 52 Week Low
  • ENTA $4.09
  • ESCA $11.74
  • 52 Week High
  • ENTA $13.43
  • ESCA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 65.93
  • ESCA 56.90
  • Support Level
  • ENTA $6.45
  • ESCA $11.99
  • Resistance Level
  • ENTA $7.73
  • ESCA $12.98
  • Average True Range (ATR)
  • ENTA 0.55
  • ESCA 0.52
  • MACD
  • ENTA 0.17
  • ESCA 0.13
  • Stochastic Oscillator
  • ENTA 90.15
  • ESCA 100.00

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.

Share on Social Networks: